Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an NDA for AXS-12 for the treatment of cataplexy in narcolepsy. Axsome anticipates ...

New Delhi has been maintaining that the May 7-10 conflict between India and Pakistan was resolved through direct talks ...